Who are in the management team of VistaGen Therapeutics, Inc.?

Jun 22 2025 10:35 PM IST
share
Share Via
As of March 2022, the management team of VistaGen Therapeutics, Inc. includes Jon Saxe (Independent Chairman), Dr. H. Ralph Snodgrass (President and Chief Scientific Officer), Shawn Singh (CEO), and Independent Directors Ann Cunningham, Dr. Jerry Gin, and Dr. Brian Underdown. They oversee the company's strategic direction and operations.
As of March 2022, the management team of VistaGen Therapeutics, Inc. includes the following individuals:

- Mr. Jon Saxe, who serves as the Independent Chairman of the Board.
- Dr. H. Ralph Snodgrass, who is the President, Founder, Chief Scientific Officer, and a Director.
- Mr. Shawn Singh, who holds the position of Chief Executive Officer and is also a Director.
- Ms. Ann Cunningham, who is an Independent Director.
- Dr. Jerry Gin, who is an Independent Director.
- Dr. Brian Underdown, who is an Independent Director.

This team is responsible for guiding the company's strategic direction and operations.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is VistaGen Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:26 PM IST
share
Share Via
Is VistaGen Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:04 AM IST
share
Share Via
What does VistaGen Therapeutics, Inc. do?
Jun 22 2025 06:48 PM IST
share
Share Via
How big is VistaGen Therapeutics, Inc.?
Jun 22 2025 06:05 PM IST
share
Share Via